These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 16909001

  • 1. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, Takahashi H, Fukumoto H, Horiguchi T, Suzuki N, Shoji M.
    Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
    [Abstract] [Full Text] [Related]

  • 2. Active Aβ vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with Aβ42-driven pathology.
    Nemirovsky A, Shapiro J, Baron R, Kompaniets A, Monsonego A.
    J Neuroimmunol; 2012 Jun 15; 247(1-2):95-9. PubMed ID: 22498096
    [Abstract] [Full Text] [Related]

  • 3. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
    Rakover I, Arbel M, Solomon B.
    Neurodegener Dis; 2007 Jun 15; 4(5):392-402. PubMed ID: 17536186
    [Abstract] [Full Text] [Related]

  • 4. Active immunization trial in Abeta42-injected P301L tau transgenic mice.
    Kulic L, Kurosinski P, Chen F, Tracy J, Mohajeri MH, Li H, Nitsch RM, Götz J.
    Neurobiol Dis; 2006 Apr 15; 22(1):50-6. PubMed ID: 16289870
    [Abstract] [Full Text] [Related]

  • 5. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF, Mohajeri MH, Huber M, Wollmer MA, Roth Z'graggen BV, Sandmeier E, Moritz E, Tracy J, Nitsch RM, Christen P.
    Neurodegener Dis; 2004 Apr 15; 1(1):20-8. PubMed ID: 16908970
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools.
    Mitani Y, Yarimizu J, Akashiba H, Shitaka Y, Ni K, Matsuoka N.
    J Neurochem; 2013 May 15; 125(3):465-72. PubMed ID: 23240999
    [Abstract] [Full Text] [Related]

  • 8. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S, Brenn A, Grube M, Niedrig K, Holtfreter S, von Bohlen und Halbach O, Groschup M, Keller M, Vogelgesang S.
    Curr Alzheimer Res; 2017 May 15; 14(6):656-667. PubMed ID: 27915995
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intracerebroventricular passive immunization with anti-Abeta antibody in Tg2576.
    Chauhan NB, Siegel GJ.
    J Neurosci Res; 2003 Oct 01; 74(1):142-7. PubMed ID: 13130516
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Assessment of the bioactivity of antibodies against beta-amyloid peptide in vitro and in vivo.
    Mohajeri MH, Gaugler MN, Martinez J, Tracy J, Li H, Crameri A, Kuehnle K, Wollmer MA, Nitsch RM.
    Neurodegener Dis; 2004 Oct 01; 1(4-5):160-7. PubMed ID: 16908985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.